ICH (QSEM Guidelines)
ICH (QSEM Guidelines)
ICH (QSEM Guidelines)
PREPARED BY
Name:- Bishal Bhattacharjee
Stream:- B.Pharm
Year:- 4th year/ Final year
Sem:- 7th sem
CONTENTS
•Introduction
•Objective of ICH
•QSEM guidelines
•Common Technical Document
•Organization & Advantages of Common Technical Document
•Silent benefits & Limitations of Common Technical
Document
•Electronic Common Technical Document
•Benefits & Advantages of Electronic Common Technical
Document
INTRODUCTION
In July 2003, the CTD became the mandatory format for new
drug application in the EU & Japan and the strongly
recommended format of choice for NDAs submitted to the
FDA. It has been adopted by several other countries including
Australia, Canada & Switzerland(2004).
ORGANIZATION OF CTD
It is organized into:
1. Module A: General Information
2. Module B: CTD summaries
3. Module C: Quality
4. Module D: Nonclinical study reports
5. Module E: Clinical study reports
ADVANTAGES OF CTD
LIMITATIONS OF CTD
• CTD is only a format, its not a single dossier with a single
content
• Legal requirements differ in the different regions
• Pharmacopoeias are not harmonized
• Applicant may have regional preferences
• ICH guidelines have not yet harmonized in all requirements
ELECTRONIC COMMON TECHNICAL DOCUMENT
The electronic Common Technical Document(eCTD) is an
interface and international specification for the Pharmaceutical
Industry to agency transfer of regulatory information. The
specification is based on the Common Technical
Document(CTD) format and was developed by the International
Council for harmonisation(ICH).
ADVANTAGE OF eCTD
1. Reviewers are already familiar with the content and
document standards
2. Local affiliates can review updates in real-time
3. Handling, managing & archiving trial and
document essential information is less time-
consuming
4. Documents are easily accessible via search &
tracking
THANK YOU